AbCellera Biologics (ABCL) Stock Insights

ABCL price $13.10 -0.54 -3.94%

Ticker
ABCL
Price
$13.10
Change
-0.54 -3.94%
Market cap ?
$4.25B
P/E ?
-21.06
Dividend yield ?
0.00%
Beta ?
1.19
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
63
Value
52
Quality
47
Growth
89

Stocklytics score rationale: value 52, quality 47, growth 89.

Financials

20182019202020212022202320242025
883100011612000233155000375203000485424000380250002883300075128000

AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or under contract, in…

Fair value

ABCL fair value $6.94. Price $13.10. Price is 89% above fair value.

Above fair value, and more expensive than usual. A larger premium than on more than 99% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 31.68M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.85% (beta 1.2). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 324.05M. Net debt 14.71M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare ABCL

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-09—-0.18—6.25M
2026-08-05-0.18-0.164.05M7.85M
2026-05-11-0.14-0.228.31M5.41M
2026-02-24-0.03-0.1844.90M6.67M
2025-11-06-0.19-0.178.96M6.31M
2025-08-07-0.12-0.1717.08M6.36M
2025-05-08-0.15-0.174.24M7.31M
2025-02-27-0.11-0.155.05M7.58M
2024-11-04-0.17-0.146.51M7.58M
2024-08-06-0.13-0.157.32M10.15M
2024-05-07-0.14-0.169.95M11.02M
2024-02-20-0.17-0.149.18M8.88M
2023-11-02-0.10-0.146.60M11.90M
2023-08-03-0.11-0.1310.06M12.46M
2023-05-04-0.14-0.1212.19M12.11M
2023-02-21-0.10-0.01485.42M50.80M
2022-11-080.080.05101.38M74.96M
2022-08-09-0.02-0.0245.92M53.59M
2022-05-100.540.38316.58M219.75M
2022-02-240.190.19139.33M122.05M
2021-11-09-0.08-0.055.51M16.20M
2021-08-12-0.010.0927.64M27.64M
2021-05-130.370.38202.74M208.08M
2021-03-290.440.61207.91M—
2020-12-140.03—11.23M—
2020-09-30-0.01—9.36M—
2020-03-31-0.01—4.66M—
2019-12-31-0.01—3.20M—
2019-09-300.00—3.45M—
2019-06-30-0.00—2.48M—
2019-03-31-0.00—2.48M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-24Hayden Michael RBuy53.61K$10.64570.44K
2026-08-18Montalbano John S.Buy10.00K$11.03110.30K
2026-08-14Booth AndrewBuy37.20K$10.32383.90K
2026-08-12Hayden Michael RBuy46.39K$10.37481.03K
2026-08-11Hayden Michael RSell50.00K——
2026-07-01Seely LynnBuy152.21K$7.851.19M
2026-07-01Sandor VictorBuy152.21K$7.851.19M
2026-06-30Seely LynnOther0——
2026-06-11Hayden Michael RBuy111.70K$5.27588.66K
2026-06-11Quake StephenBuy111.70K$5.27588.66K
2026-06-11Montalbano John S.Buy111.70K$5.27588.66K
2026-06-01Sandor VictorOther0——
2026-05-14Montalbano John S.Buy20.00K$4.7795.40K
2026-02-27Thermopylae Holdings Ltd.Buy38.00K$3.44130.72K
2026-02-27Booth AndrewBuy42.60K$3.42145.69K
2026-02-26Thermopylae Holdings Ltd.Buy177.46K$3.27580.28K
2026-01-01Booth AndrewBuy808.90K$3.422.77M
2026-01-01Hansen Carl L. G.Buy2.11M$3.427.20M
2026-01-01Stimart TrynBuy539.26K$3.421.84M
2026-01-01Lecault VeroniqueBuy539.26K$3.421.84M
2025-12-18Thermopylae Holdings Ltd.Sell225.00K——
2025-12-01Quake StephenBuy194.93K$3.47676.41K
2025-11-26Montalbano John S.Buy50.00K$3.57178.46K
2025-11-10Quake StephenOther0——
2025-11-10Quake StephenOther0——
2025-11-10Quake StephenOther0——
2025-06-12Hayden Michael RBuy238.86K$3.15752.42K
2025-06-12Montalbano John S.Buy238.86K$3.15752.42K
2025-06-12Lo AndrewBuy238.86K$3.15752.42K
2025-03-11Thermopylae Holdings Ltd.Buy343.63K$2.16742.24K
2025-03-10Montalbano John S.Buy25.00K$2.3057.50K
2025-03-06Montalbano John S.Buy60.00K$2.34140.57K
2025-01-01Stimart TrynBuy832.03K$2.932.44M
2025-01-01Lecault VeroniqueBuy832.03K$2.932.44M
2025-01-01Booth AndrewBuy1.35M$2.933.96M
2025-01-01Hansen Carl L. G.Buy2.73M$2.938.00M
2024-12-04Thermopylae Holdings Ltd.Sell286.00K——
2024-11-25Hansen Carl L. G.Sell56.12K$2.70151.54K
2024-11-25Hansen Carl L. G.Buy56.12K$2.70151.54K
2024-09-20Hansen Carl L. G.Sell56.12K$2.70151.54K
2024-09-20Hansen Carl L. G.Buy56.12K$2.70151.54K
2024-08-29Thermopylae Holdings Ltd.Buy283.52K$2.61739.98K
2024-06-21Lecault VeroniqueSell83.33K$0.1915.67K
2024-06-21Lecault VeroniqueBuy83.33K$0.1915.67K
2024-06-21Hayden Michael RBuy163.93K$2.94481.97K
2024-06-21Lo AndrewBuy163.93K$2.94481.97K
2024-06-21Montalbano John S.Buy163.93K$2.94481.97K
2024-05-31Hansen Carl L. G.Sell56.12K$2.70151.54K
2024-05-31Hansen Carl L. G.Buy56.12K$2.70151.54K
2024-02-26Hansen Carl L. G.Sell56.12K$2.70151.54K
2024-02-26Hansen Carl L. G.Buy56.12K$2.70151.54K
2024-01-14Lecault VeroniqueBuy770.42K$5.394.15M
2024-01-14Stimart TrynBuy616.33K$5.393.32M
2024-01-14Booth AndrewBuy770.42K$5.394.15M
2024-01-14Hansen Carl L. G.Buy2.10M$5.3911.29M
2023-12-19Thermopylae Holdings Ltd.Sell210.00K——
2023-11-23Hansen Carl L. G.Sell56.12K$2.70151.54K
2023-11-23Hansen Carl L. G.Buy56.12K$2.70151.54K
2023-11-08Montalbano John S.Buy10.00K$4.4644.60K
2023-11-06Montalbano John S.Buy20.00K$4.6492.80K
2023-09-22Hayden Michael RBuy20.00K$4.9198.20K
2023-09-12Lecault VeroniqueBuy20.00K$5.19103.80K
2023-08-24Hansen Carl L. G.Sell56.12K$2.70151.54K
2023-08-24Hansen Carl L. G.Buy56.12K$2.70151.54K
2023-08-08Hayden Michael RBuy30.00K$5.90177.00K
2023-05-26Hansen Carl L. G.Sell56.12K$2.70151.54K
2023-05-26Hansen Carl L. G.Buy56.12K$2.70151.54K
2023-05-26Booth AndrewBuy14.50K$6.8599.33K
2023-05-26Thermopylae Holdings Ltd.Buy153.00K$6.52997.73K
2023-05-05Lecault VeroniqueSell250.00K$0.1947.50K
2023-05-05Lecault VeroniqueBuy250.00K$0.1947.50K
2023-02-22Hansen Carl L. G.Sell56.12K$2.70151.54K
2023-02-22Hansen Carl L. G.Buy56.12K$2.70151.54K
2022-12-20Booth AndrewSell50.00K$0.199.50K
2022-12-20Booth AndrewBuy50.00K$0.199.50K
2022-12-20Booth AndrewSell50.00K$0.199.50K
2022-12-16Thermopylae Holdings Ltd.Buy85.10K$10.10859.25K
2022-12-01Lo AndrewBuy47.23K——
2022-12-01Hayden Michael RBuy47.23K——
2022-12-01Montalbano John S.Buy47.23K——
2022-12-01Lecault VeroniqueBuy462.54K——
2022-12-01Stimart TrynBuy346.90K——
2022-12-01Booth AndrewBuy485.66K——
2022-12-01Hansen Carl L. G.Buy925.07K——
2022-11-18Hansen Carl L. G.Sell56.12K——
2022-11-18Hansen Carl L. G.Buy56.12K$2.70151.54K
2022-10-31Thermopylae Holdings Ltd.Sell70.00K——
2022-08-19Thermopylae Holdings Ltd.Buy200.00K$11.462.29M
2022-08-18Hansen Carl L. G.Sell56.12K$2.70151.54K
2022-08-18Hansen Carl L. G.Buy56.12K$2.70151.54K
2022-06-14Thermopylae Holdings Ltd.Buy9.17K$8.0573.84K
2022-06-13Thermopylae Holdings Ltd.Buy54.91K$8.03441.07K
2022-06-06Thermopylae Holdings Ltd.Buy64.55K$7.50483.96K
2022-05-18Hansen Carl L. G.Sell56.12K$2.70151.54K
2022-05-18Hansen Carl L. G.Buy56.12K$2.70151.54K
2022-05-16Lecault VeroniqueBuy200.00K$6.341.27M
2022-05-13Thermopylae Holdings Ltd.Buy300.00K$7.262.18M
2022-05-12Thermopylae Holdings Ltd.Buy1.41M$6.419.02M
2022-05-12Booth AndrewBuy85.00K$5.79492.15K
2022-03-04Montalbano John S.Buy10.00K$8.5485.40K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 167, holders +15 vs prior quarter. Ownership 38.00%.

HolderSharesChangeChange %Value
BAKER BROS. ADVISORS LP33.01M2.74M+9.04%259.15M
CAPITAL WORLD INVESTORS13.59M227.25K+1.70%106.67M
TWO SIGMA INVESTMENTS, LP10.44M-124.63K-1.18%81.93M
TD WATERHOUSE CANADA INC.9.57M3.49K+0.04%72.62M
BANK OF AMERICA CORP /DE/6.14M3.14M+104.72%48.21M
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC4.32M-3.26M-43.01%33.89M
ARROWMARK COLORADO HOLDINGS LLC4.11M00.00%32.22M
BLACKROCK, INC.3.81M-234.93K-5.81%29.87M
SUSQUEHANNA INTERNATIONAL GROUP, LLP2.89M2.35M+440.35%22.66M
DRIEHAUS CAPITAL MANAGEMENT LLC2.86M-1.16M-28.82%22.49M
TUDOR INVESTMENT CORP ET AL2.06M-210.30K-9.25%16.20M
MARSHALL WACE, LLP1.90M1.54M+428.85%14.93M
UBS GROUP AG1.87M-2.34M-55.56%14.68M
MORGAN STANLEY1.67M-555.82K-24.98%13.10M
PRICE T ROWE ASSOCIATES INC /MD/1.59M1.59MNew12.46M
CITADEL ADVISORS LLC1.59M1.50M+1719.39%12.45M
NATIONAL BANK OF CANADA /FI/1.23M1.23MNew9.68M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP1.04M1.04MNew8.16M
RENAISSANCE TECHNOLOGIES LLC990.93K-519.70K-34.40%7.78M
COUNTERPOINT MUTUAL FUNDS LLC971.64K971.64KNew7.63M
CITADEL ADVISORS LLC790.30K703.10K+806.31%6.20M
STATE STREET CORP731.36K1.15K+0.16%5.74M
HRT FINANCIAL LP705.51K-529.65K-42.88%5.54M
DNB ASSET MANAGEMENT AS677.48K677.48KNew5.32M
GUARDIAN PARTNERS INC.596.00K-1.19M-66.64%4.68M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

AbCellera Biologics (ABCL) Stock Insights

ABCL$13.10-0.54 -3.94%

$4.25B

Market Cap

-21.06

P/E

—

Forward P/E

63

Score

Price History